📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. (2018)

First Author: Strangward P

Attributed to: mTOR control of effector CD4+ T cell activation during malaria infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1801737115

PubMed Identifier: 29954866

Publication URI: http://europepmc.org/abstract/MED/29954866

Type: Journal Article/Review

Volume: 115

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 28

ISSN: 0027-8424